Publications by authors named "Pranjal Kumar"

Claim this Profile
R
Recent Progression and Treatment Approaches of Kidney Fibrosis: Evidence to Clinic Approach.
Mansi Sharma, Mansi Khanna, Pranjal Kumar, Ghanshyam Das Gupta, Kalicharan Sharma

Endocr Metab Immune Disord Drug Targets· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-cancer integrated bioinformatic analysis of RNA polymerase subunits reveal RNA Pol I member CD3EAP regulates cell growth by modulating autophagy.
Nikita Bhandari, Disha Acharya, Annesha Chatterjee, Lakshana Mandve, Pranjal Kumar

Cell Cycle· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational and experimental pharmacology to decode the efficacy of L. against doxorubicin-induced organ toxicity in EAC-mediated solid tumor-induced mice.
Priyanka P Patil, Pranjal Kumar, Pukar Khanal, Vishal S Patil, Harish R Darasaguppe

Front Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical analysis of the impacts of COVID-19 pandemic on the small and large-scale tourism sectors in developing countries.
Pranjal Kumar, Pratima Ekka

Environ Dev Sustain· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple diagnosis of cancer by detecting CEA and CYFRA 21-1 in saliva using electronic sensors.
Sowmya Joshi, Shashidhar Kallappa, Pranjal Kumar, Sudhanshu Shukla, Ruma Ghosh

Sci Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An epithelial-mesenchymal plasticity signature identifies two novel LncRNAs with the opposite regulation.
Pranjal Kumar, Seema Khadirnaikar, Nikita Bhandari, Annesha Chatterjee, Sudhanshu Shukla

Front Cell Dev Biol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of an immune prognostic signature for ovarian carcinoma.
Seema Khadirnaikar, Pranjal Kumar, Sudhanshu Kumar Shukla

Cancer Rep (Hoboken)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Greedy Algorithm-Based Stem Cell LncRNA Signature Identifies a Novel Subgroup of Lung Adenocarcinoma Patients With Poor Prognosis.
Seema Khadirnaikar, Annesha Chatterjee, Pranjal Kumar, Sudhanshu Shukla

Front Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel LncRNA-based prognostic score reveals TP53-dependent subtype of lung adenocarcinoma with poor survival.
Pranjal Kumar, Seema Khadirnaikar, Sudhanshu Kumar Shukla

J Cell Physiol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma.
Seema Khadirnaikar, Pranjal Kumar, Sathiya N Pandi, Rohit Malik, Saravana M Dhanasekaran, Sudhanshu Kumar Shukla

Mol Carcinog· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PILAR1, a novel prognostic LncRNA, reveals the presence of a unique subtype of lung adenocarcinoma patients with KEAP1 mutations.
Pranjal Kumar, Seema Khadirnaikar, Sudhanshu Kumar Shukla

Gene· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis